Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McPartlin

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2016
MRI-guided prostate adaptive radiotherapy - A systematic reviewA J McPartlin, X A Li, L E Kershaw, et al.
JAMA|February 17, 2025
Manual vs AI-Assisted Prescreening for Trial Eligibility Using Large Language Models-A Randomized Clinical TrialOzan Unlu, Matthew Varugheese, Jiyeon Shin, et al.
Oral Oncology|December 27, 2024
Development of a prediction model for tube feeding dependence in HPV-associated oropharyngeal cancer patients undergoing chemoradiotherapyNicholas Dietrich, Erin Watson, Tony Tadic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2024
Reply to E. Topkan et alErin E Watson, Katrina Hueniken, Junhyung Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2024
Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based ModelErin E Watson, Katrina Hueniken, Junhyung Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Development and Standardization of a Classification System for Osteoradionecrosis: Implementation of a Risk-Based ModelErin E Watson, Katrina Hueniken, Junhyung Lee, et al.
Clinical and Translational Radiation Oncology|November 3, 2018
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trialHouda Bahig, Ying Yuan, Abdallah S R Mohamed, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2016
MRI-guided prostate adaptive radiotherapy - A systematic reviewA J McPartlin, X A Li, L E Kershaw, et al.
JAMA|February 17, 2025
Manual vs AI-Assisted Prescreening for Trial Eligibility Using Large Language Models-A Randomized Clinical TrialOzan Unlu, Matthew Varugheese, Jiyeon Shin, et al.
Oral Oncology|December 27, 2024
Development of a prediction model for tube feeding dependence in HPV-associated oropharyngeal cancer patients undergoing chemoradiotherapyNicholas Dietrich, Erin Watson, Tony Tadic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2024
Reply to E. Topkan et alErin E Watson, Katrina Hueniken, Junhyung Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2024
Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based ModelErin E Watson, Katrina Hueniken, Junhyung Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Development and Standardization of a Classification System for Osteoradionecrosis: Implementation of a Risk-Based ModelErin E Watson, Katrina Hueniken, Junhyung Lee, et al.
Clinical and Translational Radiation Oncology|November 3, 2018
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trialHouda Bahig, Ying Yuan, Abdallah S R Mohamed, et al.
Pageof 5